VanEck Pharmaceutical ETF (NASDAQ:PPH) to Issue Quarterly Dividend of $0.36

VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) announced a quarterly dividend on Wednesday, September 30th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.36 per share on Tuesday, October 6th. This represents a $1.44 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Thursday, October 1st. This is a 42.4% decrease from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248.

VanEck Pharmaceutical ETF Stock Performance

NASDAQ PPH opened at $109.47 on Thursday. The firm’s fifty day moving average price is $112.19 and its two-hundred day moving average price is $107.16. The stock has a market cap of $1.03 billion, a PE ratio of 20.21 and a beta of 0.46. VanEck Pharmaceutical ETF has a fifty-two week low of $90.60 and a fifty-two week high of $118.00.

Get VanEck Pharmaceutical ETF alerts:

About VanEck Pharmaceutical ETF

(Get Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

See Also

• Five stocks we like better than VanEck Pharmaceutical ETF
• L3Harris’ $6 Billion THAAD Win Comes at a Crucial Moment for the Stock
• Boeing’s Fighter Victory Opens the Door to Decades of Defense Revenue
• Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
• O’Reilly Automotive’s Stock Slump Hides a Stronger Business

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.